126
|
Gasperi-Campani A, Zoli W, Volpi A, Roncuzzi L, Amadori D. Inhibition of growth of breast cancer cells in vitro by the ribosome-inactivating protein saporin 6. Anticancer Res 1991; 11:1007-11. [PMID: 2064307] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/30/2022]
Abstract
The antiproliferative activity of Saporin 6, a Ribosome-inactivating protein purified from the seeds of Saponaria officinalis has been tested on human breast cancer cells in vitro by the analysis (a) of colony formation in cells from surgical specimens from 27 patients bearing primary breast cancer and (b) of protein synthesis inhibition in the MCF/7 cell line. Results indicate a very high sensitivity of breast cancer cells from most patients to a short-term treatment with Saporin 6 at concentrations (10(-9) M), until now found effective only in acellular systems or after conjugation with monoclonal antibodies. On the contrary, the treatment of the human cell line MCF/7 indicate a very reduced sensitivity compared to fresh human neoplastic cells, with the necessity of a long lag for the effect to begin.
Collapse
|
127
|
Volpi A, Turato R, Ventura G. [Leiomyoma of the esophagus compressing the left atrium]. GIORNALE ITALIANO DI CARDIOLOGIA 1991; 21:95-8. [PMID: 2055383] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 12/30/2022]
Abstract
An unusual case of leiomyoma of the middle third of the esophagus compressing the left atrium is reported. The patient was a 35-year-old man with a clinical picture mimicking pericarditis. 2-D echocardiography revealed a mediastinal mass. Leiomyoma of the esophagus was suspected on the basis of CT scan of the chest, MR study and esophagogram. The diagnosis was confirmed at operation and by histological examination.
Collapse
|
128
|
Antiga G, Volpi A, Battini G, Bignotti GC, Giordano F, Meroni M, Minazzi M, Sinico RA, Sessa A. Acute renal failure in a patient affected with Churg and Strauss syndrome. Nephron Clin Pract 1991; 57:113-4. [PMID: 2046804 DOI: 10.1159/000186229] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/30/2022] Open
|
129
|
Zoli W, Volpi A, Bonaguri C, Riccobon A, Savini S, Brizio R, Saragoni A, Medri L, Marra GA, Amadori D. An efficient method for culturing human breast carcinoma to evaluate antiblastic drug activity in vitro: experience on 136 primary cancers and on 116 recurrences. Breast Cancer Res Treat 1991; 17:231-8. [PMID: 2039842 DOI: 10.1007/bf01806372] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/29/2022]
Abstract
The feasibility of techniques developed for isolating and culturing human mammary epithelial cells of malignant origin was confirmed in 136 primary breast cancers, 116 hypodermal metastases, and 8 metastatic lymph nodes. In 115 (84%) primary breast cancers and in 81 (70%) hypodermal recurrences we observed a good in vitro cellular proliferation. These proliferating cells, at the second passage, were used for a clonal assay suitable for quantitating drug sensitivity. With this clonal assay median cloning efficiencies of 14% and 6% were obtained respectively in primaries and in skin recurrences. We examined the in vitro response to different drugs and confirmed the test's ability to detect heterogeneity in response to same drugs (doxorubicin, 4'-epidoxorubicin, vinblastine, cis platinum, and idarubicinol) among the different breast carcinoma cultures as well as heterogeneity among subpopulations within a single carcinoma.
Collapse
|
130
|
Volpi A, Battini G, Conte F, Ferrario GM, Giordano F, Sinico RA, Sessa A. Acute renal failure in elderly due to Goodpasture's syndrome. Nephron Clin Pract 1991; 57:381-2. [PMID: 2017286 DOI: 10.1159/000186297] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/29/2022] Open
|
131
|
Riccobon A, Frassineti L, Vasini M, Volpi A, Pallotti G, Flamini E, Magni E, Nunziatini R, Amadori D. [Relationship between cytosol CEA and clinico-pathologic and biologic parameters in 167 cases if primary carcinoma of the breast]. THE JOURNAL OF NUCLEAR MEDICINE AND ALLIED SCIENCES 1990; 34:27-8. [PMID: 2092130] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 12/30/2022]
|
132
|
Volpi A, Cavalli A, Santoro E, Tognoni G. Incidence and prognosis of secondary ventricular fibrillation in acute myocardial infarction. Evidence for a protective effect of thrombolytic therapy. GISSI Investigators. Circulation 1990; 82:1279-88. [PMID: 2205418 DOI: 10.1161/01.cir.82.4.1279] [Citation(s) in RCA: 46] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/30/2022]
Abstract
The multicenter randomized study of the Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico has provided the opportunity to analyze the impact of thrombolytic treatment on secondary ventricular fibrillation incidence in a large population of patients (11,712) with acute myocardial infarction. A reduction of about 20% in the frequency of secondary ventricular fibrillation was observed among patients allocated to thrombolytic treatment (streptokinase, 2.4% versus control, 2.9%; relative risk, 0.80; 95% confidence interval, 0.64-1.00). Streptokinase appeared to exert its protective effect specifically in patients treated within 3 hours of onset of symptoms (streptokinase, 2.6% versus control, 3.7%; relative risk, 0.71; 95% confidence interval, 0.53-0.95). This protection was essentially due to a reduced incidence of late ventricular fibrillation occurring after the first day of hospitalization. The 311 patients with secondary ventricular fibrillation represented an overall incidence of 2.7%. Such incidence was not related to infarct location or sex but was significantly more common in patients older than 65 years (3.3% versus 2.3% in younger patients). A significant excess of in-hospital deaths was found in patients with secondary ventricular fibrillation compared with those in the reference group (38% versus 24%; relative risk, 1.98; 95% confidence interval, 1.56-2.52). Conversely, secondary ventricular fibrillation was not a predictor of 1-year mortality for hospital survivors. Thrombolytic treatment with intravenous streptokinase affords protection against secondary ventricular fibrillation most probably by a limitation of infarct size. When the arrhythmia complicates the course of infarction, it is associated with an adverse short-term outcome, whereas the long-term prognosis is not influenced.
Collapse
|
133
|
Amadori D, Frassineti L, Riccobon A, Volpi A, Vasini M, Nanni O, Zoli W, Pallotti G. [Cytosol CEA: a prognosis factor in breast carcinoma? (personal experience with 76 cases)]. THE JOURNAL OF NUCLEAR MEDICINE AND ALLIED SCIENCES 1990; 34:25-6. [PMID: 2092127] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 12/30/2022]
|
134
|
Paccagnella A, Favaretto A, Brandes A, Ghiotto C, Fornasiero A, Volpi A, Pappagallo G, Festi G, Cipriani A, Vinante O. Cisplatin, etoposide, and ifosfamide in non-small cell lung carcinoma. A phase II randomized study with cisplatin and etoposide as the control arm. Cancer 1990; 65:2631-4. [PMID: 2160312 DOI: 10.1002/1097-0142(19900615)65:12<2631::aid-cncr2820651205>3.0.co;2-y] [Citation(s) in RCA: 18] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/30/2022]
Abstract
A Phase II randomized study testing the combination of cisplatin, etoposide, and ifosfamide (PEI) in non-small cell lung cancer (NSCLC) was performed. The standard combination of cisplatin and etoposide (PE) was used as the control arm. Since January 1987, 78 patients were enrolled and then stratified for previous treatments and performance status (PS). The response rate (RR) of PEI was 26% (95% confidence limits [95 CL], 12% to 40%), with one complete response (CR). The RR of PE was 26% (95 CL, 13% to 39%), with no CR. The median response duration was 5 months (range, 2 to 13 months) for PEI and 4 months (range, 2 to 6 months) for PE. The median survival time was 6 months (range, 1 to 22+ months) for PEI and 7 months (range, 1 to 21+ months) for PE. Leukopenia at recycling was similar in both arms (25% for PEI and 29% of PE). The median leukocyte nadir was 2100/microliters (range, 430 to 4870/microliters) for PEI patients and 3150/microliters (range, 500 to 5000/microliters) for PE patients. Three patients had a drug-related death secondary to infections. This Phase II randomized study suggested that the combination of cisplatin plus etoposide and ifosfamide produces results similar to those obtainable with cisplatin and etoposide.
Collapse
|
135
|
Smith HS, Zoli W, Volpi A, Hiller A, Lippman M, Swain S, Mayall B, Dollbaum C, Hackett AJ, Amadori D. Preliminary correlations of clinical outcome with in vitro chemosensitivity of second passage human breast cancer cells. Cancer Res 1990; 50:2943-8. [PMID: 2334895] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/31/2022]
Abstract
These studies describe the clinical correlations of 63 in vitro chemosensitivity assays on breast cancer cells after short-term monolayer culture. Forty-five of the assays were single agent correlations. Based on cut-off values determined empirically, the test accurately predicted resistance for 36 of 41 patients (88%) who did not respond to the drug. It also predicted sensitivity with a high degree of accuracy: 21 of 22 patients (95%) who responded to the drug tested had a sensitive assay. In five cases, two biopsies were evaluated from the same patient. Whenever assays were performed before and after treatment with a given drug, tumor cells from the second biopsy were more resistant in vitro if the patient failed on therapy. If the patient did not fail, but stopped therapy for other reasons, or if there was no intervening therapy with the tested drug, the two biopsies remained similar in drug sensitivity. These results suggest that in vitro chemosensitivity assays which accurately predict both sensitivity and resistance can be obtained with breast cancer cells after short-term culture and that further prospective trials are warranted.
Collapse
|
136
|
Meroni M, Volpi A, Usberti M, Battini G, Tarelli LT, Giordano F, Sessa A. Two brothers with idiopathic membranous nephropathy and familial sensorineural deafness. Am J Kidney Dis 1990; 15:269-72. [PMID: 2305767 DOI: 10.1016/s0272-6386(12)80773-6] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/31/2022]
Abstract
Genetic factors could play an important role in the pathogenesis of idiopathic membranous nephropathy, and a few cases of familial membranous nephropathy have been described: an increased incidence of some HLA antigens as DR3 and others has been reported. We present two brothers with idiopathic membranous nephropathy and sensorineural deafness. HLA typing was performed in the two patients and in the members of the family, and it showed the absence of linkage of an HLA antigen with the renal disease in the family.
Collapse
|
137
|
De Vita C, Franzosi MG, Geraci E, Maggioni AP, Mauri F, Mezzanotte G, Tavazzi L, Tognoni G, Volpi A. GISSI-2: mortality plus extensive left-ventricular damage as "end-point". Lancet 1990; 335:289. [PMID: 1967740 DOI: 10.1016/0140-6736(90)90104-d] [Citation(s) in RCA: 17] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/29/2022]
|
138
|
Volpi A, Cavalli A, Franzosi MG, Maggioni A, Mauri F, Santoro E, Tognoni G. One-year prognosis of primary ventricular fibrillation complicating acute myocardial infarction. The GISSI (Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto miocardico) investigators. Am J Cardiol 1989; 63:1174-8. [PMID: 2565684 DOI: 10.1016/0002-9149(89)90174-4] [Citation(s) in RCA: 62] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/01/2023]
Abstract
The 1-year prognosis of 293 patients discharged alive from the hospital after acute myocardial infarction (AMI), who experienced primary ventricular fibrillation (VF) in the acute phase, was compared with that of a reference group of 6,337 patients identified from the same population included in the Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto miocardico (GISSI) trial. There was no difference in the 6- and 12-month mortality between the patients with primary VF and the reference group (3.7 vs 2.7% and 4.1 vs 4.2%, respectively). Survival of the 2 groups was also similar when patients were stratified according to infarct site (anterior and posterior), and whether or not they received treatment with streptokinase during AMI. Thus, long-term mortality of patients discharged alive after AMI complicated by primary VF is low and is not influenced by previous fibrinolytic therapy or by infarct site. The excess mortality of patients with primary VF is confined to the hospital phase, after which survivors represent a low-risk subgroup.
Collapse
|
139
|
Praderio L, Corti C, Sposato E, Taccagni GL, Volpi A, Sabbadini MG. Berger's disease with polyarteritis nodosa. BRITISH JOURNAL OF RHEUMATOLOGY 1989; 28:161-3. [PMID: 2565129 DOI: 10.1093/rheumatology/28.2.161] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/01/2023]
Abstract
We describe a patient with Berger's disease and polyarteritis nodosa. This association has not been described previously in the literature. A causal relationship between the two diseases is suggested.
Collapse
|
140
|
Sardeo G, Venza E, Dalla Pria AF, Caroli A, Volpi A, Galassi A. [Variability in immunologic aspects of Whipple's disease. Is a unitary interpretation possible?]. RECENTI PROGRESSI IN MEDICINA 1989; 80:119-22. [PMID: 2472655] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/01/2023]
Abstract
A case of Whipple's disease with histological and ultrastructural studies, characterized by unusual bacteriological and immunologic findings, is reported. Alpha hemolytic Streptococcus and Candida tropicalis were isolated from the culture of the intestinal biopsy specimens. The immunological function study showed a global defect both of humoral and cellular immunity. On the basis of the literature review, the Authors debate a unitary interpretation of the various immunological dysfunctions reported in this disease.
Collapse
|
141
|
Volpi A, Ferrario GM, Giordano F, Antiga G, Battini G, Fabbri C, Meroni M, Sessa A. Acute renal failure due to hypersensitivity interstitial nephritis induced by warfarin sodium. Nephron Clin Pract 1989; 52:196. [PMID: 2500616 DOI: 10.1159/000185636] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/01/2023] Open
|
142
|
Volpi A, Pica F, Cauletti M, Panà A, Rocchi G. Cytomegalovirus infection in day care centers in Rome, Italy: viral excretion in children and occupational risk among workers. J Med Virol 1988; 26:119-25. [PMID: 2846774 DOI: 10.1002/jmv.1890260203] [Citation(s) in RCA: 17] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/02/2023]
Abstract
From nine day care centers in Rome, Italy, 253 children of middle to low socioeconomic classes were examined for cytomegalovirus (CMV) excretion in saliva. The overall excretion rate was 13%, with no marked differences between centers. Socioeconomic level, age of enrollment, chronological age, length of attendance, and number of siblings did not have any discernible influence on viral shedding. The most notable result is that during the second year of age, 100% of the excretors had been breast fed, but only 60% in the third year, indicating that maternal transmission is the most likely source of children's infection early in life. Serologic survey of 82 female workers in day care centers, 82 matched housewives, and 229 female students aged 14 to 18 years who were in training to care for children showed that at 14 years of age the CMV seropositivity rate is 85, which suggests that primary infection during childbearing age is an uncommon event in Rome.
Collapse
|
143
|
Volpi A, Maggioni AP. [Xamoterol]. MEDICINA (FLORENCE, ITALY) 1988; 8:473-5. [PMID: 2907597] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/03/2023]
|
144
|
Sessa A, Ferrario GM, Volpi A, Conte F, Giordano F. Glomerular tip nephropathy. Clin Nephrol 1988; 30:173. [PMID: 3180525] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/04/2023] Open
|
145
|
Caroli A, Sardeo G, Gasparoni P, Volpi A, Cecchetto G, Piaserico GP. [Relations between plasma insulin and biliary calculosis in diabetic patients]. MINERVA DIETOLOGICA E GASTROENTEROLOGICA 1988; 34:205-8. [PMID: 3059232] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/03/2023]
|
146
|
Sardeo G, Venza E, Castronovo S, Volpi A, Vespignani S, Pulido E, Artusi T. [Acute myelofibrosis, an open problem; immunohistochemical study of 2 cases]. RECENTI PROGRESSI IN MEDICINA 1988; 79:253-6. [PMID: 3047820] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/03/2023]
|
147
|
Maggioni AP, Volpi A. [Encainide]. MEDICINA (FLORENCE, ITALY) 1988; 8:229-32. [PMID: 3147354] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/04/2023]
|
148
|
Volpi A, Cavalli A, Maggioni AP, Pieri-Nerli F. Left atrial compression by a mediastinal bronchogenic cyst presenting with paroxysmal atrial fibrillation. Thorax 1988; 43:216-7. [PMID: 3406909 PMCID: PMC461176 DOI: 10.1136/thx.43.3.216] [Citation(s) in RCA: 28] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/05/2023]
|
149
|
Cavalli A, Maggioni AP, Marchi S, Volpi A, Latini R. Flecainide half-life prolongation in 2 patients with congestive heart failure and complex ventricular arrhythmias. Clin Pharmacokinet 1988; 14:187-8. [PMID: 3131059 DOI: 10.2165/00003088-198814030-00007] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/04/2023]
|
150
|
Afeltra A, Caccavo D, Giorgi A, Mancino R, Volpi A, Bonomo L. [A case of rubella arthritis with Tietze syndrome with variable common hypogammaglobulinemia]. RECENTI PROGRESSI IN MEDICINA 1988; 79:64-6. [PMID: 3291025] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/05/2023]
|